Treatments that ramp up supervision of the tiny "motors" that power cells may have promise for treating one of the most common forms of inborn neuromuscular disease, by the numbers to a report in the September Cell Metabolism, a Cell Press publication. Neuromuscular disorders caused by defects in those mitochondrial motors affect a large number of propagation and adults worldwide, but today remain without treatment, the researchers said.

More: - Read More